PTG.WA
Price:
$25.8
Market Cap:
$152.64M
Poltreg S.A. is a biotechnology enterprise based in Gdansk, Poland, specializing in the creation of therapeutic solutions for autoimmune conditions. The company's research and development efforts are centered on harnessing T-regulatory cells to develop treatments, specifically targeting type 1 diabetes in children and multiple sclerosis.
Industry
Biotechnology
IPO Date
2021-11-23
Stock Exchange
WSE
Ticker
PTG.WA
According to Poltreg S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -4.88. This represents a change of 14.97% compared to the average of -4.24 of the last 4 quarters.
The mean historical PE Ratio of Poltreg S.A. over the last ten years is -96.24. The current -4.88 PE Ratio has changed 407.08% with respect to the historical average. Over the past ten years (40 quarters), PTG.WA's PE Ratio was at its highest in in the June 2022 quarter at 560.65. The PE Ratio was at its lowest in in the December 2020 quarter at -229.59.
Average
-96.24
Median
-86.32
Minimum
-238.42
Maximum
-4.39
Discovering the peaks and valleys of Poltreg S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 73.52%
Maximum Annual PE Ratio = -4.39
Minimum Annual Increase = -84.47%
Minimum Annual PE Ratio = -238.42
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -4.39 | -51.89% |
| 2024 | -9.13 | -46.34% |
| 2023 | -17.01 | -84.47% |
| 2022 | -109.52 | 73.52% |
| 2021 | -63.12 | -73.53% |
| 2020 | -238.42 | 34.62% |
| 2019 | -177.11 | 17.14% |
The current PE Ratio of Poltreg S.A. (PTG.WA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.18
5-year avg
-40.63
10-year avg
-96.24
Poltreg S.A.’s PE Ratio is greater than Molecure S.A. (-8.47), less than Mabion S.A. (-2.11), greater than NanoGroup S.A. (-8.40), less than Pure Biologics Spólka Akcyjna (-2.02), greater than Medinice S.A. (-98.54), greater than Genomtec S.A. (-6.42), greater than Urteste S.A. (-9.09), greater than Pharmena S.a. (-12.16), greater than Captor Therapeutics Spolka Akcyjna (-9.07), less than Airway Medix S.A. (17.52),
| Company | PE Ratio | Market cap |
|---|---|---|
| -8.47 | $124.67M | |
| -2.11 | $120.41M | |
| -8.40 | $104.01M | |
| -2.02 | $23.44M | |
| -98.54 | $750.36M | |
| -6.42 | $69.79M | |
| -9.09 | $68.52M | |
| -12.16 | $34.08M | |
| -9.07 | $443.34M | |
| 17.52 | $30.85M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poltreg S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Poltreg S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Poltreg S.A.'s PE Ratio?
How is the PE Ratio calculated for Poltreg S.A. (PTG.WA)?
What is the highest PE Ratio for Poltreg S.A. (PTG.WA)?
What is the 3-year average PE Ratio for Poltreg S.A. (PTG.WA)?
What is the 5-year average PE Ratio for Poltreg S.A. (PTG.WA)?
How does the current PE Ratio for Poltreg S.A. (PTG.WA) compare to its historical average?